1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Endometrial cancers

Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA963) [ID6426]

Awaiting development [GID-TA11536] Expected publication date: 21 May 2025

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Invitation to participate

  • Final scope PDF 167 KB 31 July 2024  
  • Final stakeholder list PDF 172 KB 31 July 2024  
  • NICE's response to comments on the draft scope and provisional stakeholder list PDF 220 KB 31 July 2024  
  • Equality impact assessment (scoping) PDF 144 KB 31 July 2024  

Draft scope documents

  • Draft scope and provisional stakeholder list comments table (post-referral) MSWord 44 KB 31 July 2024  
  • Provisional stakeholder list (post-referral) MSWord 35 KB 31 July 2024